Fort Washington, PA, United States of America

James David Winkler

This inventor holds 10 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, Johns Hopkins University, Other. Active years: 1995-2002.

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 121(Granted Patents)

Company Filing History:

7 out of 2,198

Smithkline Beecham Corporation

patents

3 out of 3,795

Johns Hopkins University

patents

3 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1995-2002

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6451785 - Beta lactams as antiproliferative agents (2002-09-17),

2. 6376653 - Tie2 antagonist antibodies (2002-04-23),

3. 6372741 - Use of CSAID™ compounds as inhibitors of angiogenesis (2002-04-16),

4. 6365154 - Tie2 agonist antibodies (2002-04-02),

5. 6221860 - Beta-lactam inhibitors of CoA-IT (2001-04-24),

6. 5912270 - Anti-inflammatory compounds (1999-06-15),

7. 5663053 - Inhibition of inflammatory lipid mediators (1997-09-02),

8. 5648373 - CoA-IT and PAF inhibitors (1997-07-15),

9. 5496855 - Anti-inflammatory compounds (1996-03-05),

10. 5470882 - Anti-inflammatory compounds (1995-11-28),

Title: The Innovations of James David Winkler

Introduction

James David Winkler is a notable inventor based in Fort Washington, PA (US). He has made significant contributions to the field of science and medicine, holding a total of 10 patents. His work primarily focuses on developing methods and compounds that have the potential to improve health outcomes.

Latest Patents

Winkler's latest patents include groundbreaking research on beta lactams as antiproliferative agents. This method involves administering an effective amount of CoA-independent transacylase inhibiting compounds to inhibit or reduce cell proliferation in humans or mammals. Another significant patent involves Tie2 antagonist antibodies, which are disclosed for their use in inhibiting angiogenesis and other medical applications.

Career Highlights

Throughout his career, Winkler has worked with prominent companies, including SmithKline Beecham Corporation. His innovative approaches have led to advancements in medical treatments and therapies, showcasing his dedication to improving human health.

Collaborations

Winkler has collaborated with esteemed colleagues such as Floyd Harold Chilton, III and Stephen Dudley Holmes. These partnerships have further enriched his research and development efforts.

Conclusion

James David Winkler's contributions to the field of medicine through his patents and collaborations highlight his role as a significant innovator. His work continues to influence advancements in health and science.